Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue 3
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Immunotherapy biomarkers
Original research
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma
Online download statistics by month:
Online download statistics by month: March 2022 to February 2023
Abstract
Full
Pdf
Mar 2022
283
287
103
Apr 2022
432
443
252
May 2022
205
207
88
Jun 2022
167
173
67
Jul 2022
162
166
51
Aug 2022
198
205
64
Sep 2022
178
182
77
Oct 2022
176
178
64
Nov 2022
128
129
62
Dec 2022
109
109
45
Jan 2023
93
93
50
Feb 2023
137
138
87
Total
2268
2310
1010
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF